Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-14

Clinical Trial Update: User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015 [NA]

View source ↗

Summary

A completed clinical trial evaluating the performance of four blood glucose monitoring systems (Contour Plus One, Accu-Chek Performa Connect, FreeStyle Optium N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Accu-Chek Performa Connect
  • Contour Plus One
  • FreeStyle Optium Neo
  • OneTouch Select Plus

Snippet

Sponsor: Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm | Conditions: Diabetes | NA | Status: COMPLETED